Document is current
Any future updates will be listed below
-
Authors
Palm, Julia https://orcid.org/0000-0003-1568-5893
Alaid, Ssuhir
Ammon, Danny
Brandes, Julian
Dürschmid, Andreas
Fischer, Claudia
Fortmann, Jonas https://orcid.org/0000-0003-1757-525X
Friebel, Kristin
Geihs, Sarah
Hartig, Anne-Kathrin
He, Donghui
Heidel, Andrew J.
Hetfeld, Petra
Ihle, Roland https://orcid.org/0000-0002-8502-7303
Kahle, Suzanne
Koi, Verena
Konik, Margarethe
Kretzschmann, Frauke
Kruse, Henner
Lippmann, Norman
Lübbert, Christoph
Marx, Gernot
Mikolajczyk, Rafael
Mlocek, Anne
Moritz, Stefan https://orcid.org/0000-0001-9503-9642
Müller, Christoph
Müller, Susanne
Pérez Garriga, Ariadna https://orcid.org/0000-0001-8840-1770
Phan-Vogtmann, Lo An
Pietzner, Diana
Pletz, Mathias W.
Popp, Mario
Rebenstorff, Maike
Renz, Jonas
Rißner, Florian
Röhrig, Rainer https://orcid.org/0000-0002-0032-5118
Saleh, Kutaiba
Schönherr, Sebastian G.
Spreckelsen, Cord
Stempel, Anja
Stolz, Abel
Thomas, Eric
Thon, Susanne https://orcid.org/0009-0004-0254-2935
Tiller, Daniel
Uschmann, Sebastian
Wendt, Sebastian
Wendt, Thomas
Winnekens, Philipp
Witzke, Oliver
Hagel, Stefan
Scherag, André
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01ZZ1803C, 01ZZ1803C, 01ZZ1803D, 01ZZ1803D, 01ZZ1803C, 01ZZ1803B, 01ZZ1803C, 01ZZ1803B, 01ZZ1803N, 01ZZ1803P, 01ZZ1803C, 01ZZ1803B, 01ZZ1803P, 01ZZ1803D, 01ZZ1803D, 01ZZ1803P, 01ZZ1803B, 01ZZ1803C, 01ZZ1803D, 01ZZ1803D, 01ZZ1803B, 01ZZ1803N, 01ZZ1803N, 01ZZ1803B, 01ZZ1803C, 01ZZ1803B, 01ZZ1803C, 01ZZ1803N, 01ZZ1803C, 01ZZ1803N, 01ZZ1803D, 01ZZ1803C, 01ZZ1803C, 01ZZ1803B, 01ZZ1803C, 01ZZ1803D, 01ZZ1803C, 01ZZ1803P, 01ZZ1803D, 01ZZ1803C, 01ZZ1803C, 01ZZ1803N, 01ZZ1803C, 01ZZ1803N, 01ZZ1803D, 01ZZ1803P, 01ZZ1803P, 01ZZ1803C, 01ZZ1803C)
- License Information
-
More Information
Article History
Received: 10 April 2024
Accepted: 13 March 2025
First Online: 28 March 2025
Competing interests
: O.W. has received research grants for clinical studies, speaker fees, honoraria and travel expenses from Amgen, Alexion, Astellas, Astra Zeneca, Basilea, Biotest, Bristol-Myers Squibb, Correvio, Chiesi, Gilead, GSK; Hexal, Janssen, Dr. F. Köhler Chemie, MSD, Novartis, Roche, Pfizer, Sanofi, Takeda, TEVA, Tillotts Pharma and UCB. OW is supported by an unrestricted grant from the Rudolf-Ackermann-Stiftung (Stiftung für Klinische Infektiologie). MPl has received speaker fees and honoraria from MSD, Pfizer, GSK, Gilad, Thermo Fisher, Infectopharm, Roche and BioNtech and has received a Pfizer grant for a study on CAP. SH has received speaker fees from Pfizer, MSD, Infectopharm, Philips, Advanz, Beckman Coulter, Shionogi, and Tillots. G.M. has received speaker fees and honoraria from März AG, BBraun Melsungen and 4TEEN4. The remaining authors declare no competing interests.
